Thomas G. Roberts Jr

Thomas G. Roberts Jr

Signal active

Partner, Principal and Portfolio Manager

Bio

Dr. Roberts joined us in 2005. Prior to joining us, Dr. Roberts was an attending oncologist at Massachusetts General Hospital, an Instructor of Medicine at the Harvard Medical School, and a Visiting Scientist at Massachusetts Institute of Technology. He is board certified in Medical Oncology. Dr. Roberts obtained two baccalaureate degrees (summa cum laude) from the University of Pennsylvania, including a B.S. from the Wharton School of Business (elected Phi Beta Kappa junior year). He obtained his medical degree from Harvard Medical School. Dr. Roberts performed his internal medicine training at the Massachusetts General Hospital and his medical oncology training through the Dana-Farber/Partners Cancer Care Oncology Fellowship Program.

Location

San Francisco, California, United States, North America

Social

Primary Organization

Farallon Capital Management

Farallon Capital Management

Founded

1986

Investment

86

Lead investment

21

Exits

45

Employees

251-500

Industry

Financial Services, Finance, Photography

Jobs history

0

N/A

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Thomas G. Roberts Jr is the Partner, Principal and Portfolio Manager at Farallon Capital Management, based in United States, North America. With a background in Financial Services, Thomas G. Roberts Jr has a rich history of leadership and innovation. Thomas G. Roberts Jr studied MD Medicine @ Harvard Medical School. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

N/A

Number of investment

1

Number of exits

0

Personal investment

0

There is no personal investment available on this profile

Partner investment

0

There is no partner investment available on this profile

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.